India Glycols demerger effective; splits into three listed entities

Demerger Ratio AnnouncedNclt Scheme FiledStrategic Transactions View source PDF Explain this filing

INDIAGLYCO · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-78.7%Reaction day

₹1106.80

prior close

—

announcement price

After-mkt

timing

Nifty Microcap 250market-0.6%-78.1% vs market

Breweries & Distilleries peers, median of 25sector-0.3%-78.3% vs sector

On the reaction day the stock moved 78.1 pts less than Nifty Microcap 250 and 78.3 pts less than its Breweries & Distilleries peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

—

10m

—

15m

—

30m

—

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-78.7-0.6-78.1-0.3-78.3

Next day

-77.6+0.0-77.6-0.3-77.3

-76.5+0.7-77.2-0.0-76.4

-75.3+1.1-76.4-0.9-74.4

-74.1+1.6-75.7-0.9-73.2

-72.8+1.5-74.3-2.1-70.7

-73.4+1.4-74.7-2.6-70.8

15d

-72.1+0.4-72.5-4.4-67.7

-72.6-1.4-71.2-6.5-66.1

—————

UpDownMarket · Nifty Microcap 250Sector · Breweries & Distilleries peers, median of 25Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

India Glycols has demerged into three entities effective September 1, 2026, after NCLT order filed with the Registrar. The original company keeps chemicals, glycols and industrial gases business (Rs 345 crore Q1 revenue). IGL Spirits houses the spirits business including IMFL and country liquor (Rs 694 crore). Ennature Bio Pharma houses bio-pharma and bio-polymers (Rs 90 crore). Shareholders on record date September 2, 2026 will get 1 IGL Spirits share per 1 IGL share and 1 Ennature Bio Pharma share per 3 IGL shares. Both new entities will apply for BSE and NSE listing.

Likely market impact

Shareholders get additional shares in two new companies. Both new entities will separately list on BSE and NSE, offering focused pure-play exposure.